Biohaven’s Nurtec, with dual migraine approvals, hits $136M in quarterly sales and leads the pack in market share esagonowsky Tue, 10/05/2021 – 10:36 More: Biohaven's Nurtec, with dual migraine approvals, hits 6M in quarterly sales and leads the pack in
read moreGlaxoSmithKline relocates U.S. operations in Philadelphia, North Carolina as COVID-19 cuts its office space needs aliu Tue, 10/05/2021 – 10:34 More: GlaxoSmithKline relocates U.S. operations in Philadelphia, North Carolina as COVID-19 cuts its office space needs Source: fierce
read moreBayer pledges $464M to upgrade, build production facilities in contraceptives push jkeenan Tue, 10/05/2021 – 09:45 More: Bayer pledges 4M to upgrade, build production facilities in contraceptives push Source: fierce
read moreAs Revance nears a potential launch for its Botox rival, AbbVie sues for patent infringement esagonowsky Tue, 10/05/2021 – 09:32 More: As Revance nears a potential launch for its Botox rival, AbbVie sues for patent infringement Source: fierce
read moreCambrex to pump $30M into expanding North Carolina manufacturing site jkeenan Tue, 10/05/2021 – 08:40 More: Cambrex to pump M into expanding North Carolina manufacturing site Source: fierce
read morePrivate biopharmaceutical research, development, and commercialisation company, AiPharma, has announced a strategic alliance with biopharmaceutical company Appili Therapeutics Inc (Appili), to advance the global development of Avigan®/Reeqonus™ (favipiravir). More: AiPharma forms alliance with Appili Therapeutics Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals